CareRx Announces Q1 2026 Dividend
Toronto, Ontario--(Newsfile Corp. - March 4, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate care communities, today announced that the Company's Board of Directors has declared a dividend of CAD$0.02 per outstanding common share of the Company ("Common Shares"), payable on April 9, 2026, to holders of record of Common Shares as of the close
2026-03-04 7:42 PM EST | CareRx Corporation
CareRx Reports 2025 Year-End and Fourth Quarter Results
Toronto, Ontario--(Newsfile Corp. - March 4, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate care communities, today reported its financial results for the fourth quarter and full year ended December 31, 2025. Highlights for the Year and Fourth Quarter of 2025 Average Beds Serviced1 in the fourth quarter of 2
2026-03-04 7:40 PM EST | CareRx Corporation
Adia Nutrition Announces Submission of Final Revised Protocol for Lower Back Pain Study with AdiaVita
Winter Park, Florida--(Newsfile Corp. - March 3, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a company focused on regenerative medicine and therapeutic solutions, today announced that its subsidiary, Adia Med of Winter Park, LLC, has submitted its final revised protocol to the Institutional Review Board (IRB) for the lower back pain clinical study.
Soins de santé et hôpitaux, Santé
2026-03-03 10:20 AM EST | Adia Nutrition Inc.
Canadian Pulmonary Fibrosis Foundation: Oxygen Therapy Saves Lives and Health Care Dollars
Toronto, Ontario--(Newsfile Corp. - March 3, 2026) - Oxygen therapy is a lifeline for people living with chronic lung diseases like pulmonary fibrosis. It reduces hospitalizations and improves quality of life. Yet across Canada, access to medically necessary oxygen therapy depends on where a person lives, inconsistent qualification criteria and, in some cases, one's ability to pay. The Canadian Pulmonary Fibrosis Foundation (CPFF) is calling on health authorities to designate supplemental oxy
Soins de santé et hôpitaux, Santé
2026-03-03 9:21 AM EST | Canadian Pulmonary Fibrosis Foundation
Light-Activated Ruvidar and Interferon Demonstrate Enhanced Efficacy
Toronto, Ontario--(Newsfile Corp. - March 2, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of cancer, bacteria and viruses, is pleased to announce that recent in vitro data demonstrates an enhanced bladder cancer cell kill, when light-activated Ruvidar®
Technologies, Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique
2026-03-02 7:00 AM EST | Theralase Technologies Inc.
HEALWELL to Participate in Upcoming TD Cowen, Scotiabank and ROTH Investor Conferences
Toronto, Ontario--(Newsfile Corp. - February 27, 2026) - HEALWELL AI Inc.(TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care
Technologies, Soins de santé et hôpitaux
2026-02-27 7:00 AM EST | HEALWELL AI
New National Polling Shows Strong Support for Prevention-Focused Dental Hygiene Care While Gaps in Access to Care Persist
Ottawa, Ontario--(Newsfile Corp. - February 26, 2026) - New national public opinion research released today by the Canadian Dental Hygienists Association (CDHA) shows Canadians place exceptionally high trust in dental hygienists and strongly support prevention-focused dental hygiene care, while also acknowledging that barriers to access remain. The polling, conducted by Abacus Data, found that 96 per cent of Canadians hold a positive impression of dental hygienists, with more than eight in te
Soins de santé et hôpitaux, Santé
2026-02-26 9:40 AM EST | Canadian Dental Hygienists Association
Un nouveau sondage national montre un soutien massif aux soins d'hygiène dentaire axés sur la prévention tandis que des obstacles à l'accès aux soins persistent
Ottawa, Ontario--(Newsfile Corp. - 26 février 2026) - Une nouvelle recherche sur l'opinion publique nationale publiée aujourd'hui par l'Association canadienne des hygiénistes dentaires (ACHD) indique que les Canadiennes et Canadiens accordent une confiance exceptionnellement élevée aux hygiénistes dentaires et sont très favorables aux soins d'hygiène dentaire axés sur la prévention tout en reconnaissant la persistance d'obstacles à l'accè
Soins de santé et hôpitaux, Santé
2026-02-26 9:40 AM EST | Canadian Dental Hygienists Association
OTF + Lilly Collaboration Update on Registration Response | OMA QI Scaling Initiative Gains National Response, Bringing Together Diverse Practice Types Across 39 States
Denver, Colorado--(Newsfile Corp. - February 26, 2026) - The Obesity Medicine Association (OMA) is seeing strong early momentum for its Implementation into Practice Collaborative (IPC), a program designed to help clinicians strengthen obesity care through practical, evidence-based improvements in outpatient settings. The IPC is part of a multi-phase Quality Improvement (QI) initiative created specifically for OMA members. It was developed in collaboration with the Obesity Treatment Foun
Soins de santé et hôpitaux, Santé
2026-02-26 8:00 AM EST | Obesity Medicine Association
LevelJump Announces Grant of Stock Options
Toronto, Ontario--(Newsfile Corp. - February 26, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("Leveljump" or the "Company") announces that, pursuant to the Company's 2022 Equity Incentive Plan, it has granted an aggregate of 2,250,000 incentive stock options (the "Options") to three directors of the Company. Each Option entitles the optionee to acquire one common share of the Company at an exercise price of $0.065 per common share until February 24, 2031. There are no vesting restrictions
Soins de santé et hôpitaux, Santé
2026-02-26 8:00 AM EST | LevelJump Healthcare Corp.
HEALWELL AI Expands Global Footprint with First AI Implementation in Middle East and Growing Enterprise Adoption Across Canada and the United States
HEALWELL has signed its first contract to deliver AI solutions in the Middle East to a major governmental health system, marking a key step in its global expansion. This new deployment to an existing Orion Health customer demonstrates the scalability of the DARWEN™ platform and reinforces the Company's commitment to improving patient care worldwide. HEALWELL is deploying SMART Identify, SMART Search, and SMART Summary across healthcare systems in Canada and the U.S., improv
Technologies, Soins de santé et hôpitaux
2026-02-26 3:15 AM EST | HEALWELL AI
FY25 Results: Resilient Performance with Strong Profit Gains in Challenging Markets
Baar, Switzerland--(Newsfile Corp. - February 26, 2026) - Ad hoc announcement pursuant to Art. 53 LR MEDIA RELEASE Ad hoc announcement pursuant to Art. 53 LR Full-Year 2025 Results
Technologies, Construction / bâtiments, Soins de santé et hôpitaux, Produits ménagers / de consommation / cosmétiques
2026-02-26 12:09 AM EST | medmix AG
CareRx Corporation to Host Annual and Fourth Quarter 2025 Financial Results Conference Call on Thursday, March 5, 2026 at 8:30 a.m. ET
Toronto, Ontario--(Newsfile Corp. - February 25, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company") today announced it will host a conference call to discuss its annual and fourth quarter 2025 financial results on Thursday, March 5, 2026, at 8:30 a.m. Eastern Time (ET). The Company expects to report its annual and fourth quarter 2025 financial results for the period ended December 31, 2025, after market close on Wednesday, March 4, 2026. Telephone Dial-
2026-02-25 7:30 AM EST | CareRx Corporation
Scryb Reports Positive Q1 2026: Cash Increased 50%, Liabilities Down 27%, Remains Largest Shareholder of Cybeats
Toronto, Ontario--(Newsfile Corp. - February 25, 2026) - Scryb Inc. (CSE: SCYB) ("Scryb" or the "Company") announces that it has filed its audited consolidated financial statements and Management's Discussion and Analysis for the fiscal quarter ended December 31, 2025 ("Q1 2026"). The filings are available on SEDAR+. Q1 2026 Highlights Cash position improved by 50% to $1.2 million (from $0.8 million at September 30, 2025), with working capital rising 6
Biotechnologies, Soins de santé et hôpitaux, Santé
2026-02-25 7:01 AM EST | NorthPalm Capital Corp.
Adia Med of Winter Park Expands into Cosmetics Due to High Patient Demand - Now Interviewing Nurse Practitioners for Hair Growth and Aesthetic Procedures
Winter Park, Florida--(Newsfile Corp. - February 24, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and innovative wellness solutions through its subsidiary Adia Med, today announced that its Winter Park clinic is actively interviewing candidates for a Nurse Practitioner position specializing in cosmetic treatments, including advanced hair growth therapies.
Soins de santé et hôpitaux, Santé
2026-02-24 8:30 AM EST | Adia Nutrition Inc.
Envoy Medical Regains Compliance with Nasdaq Listing Requirement
White Bear Lake, Minnesota--(Newsfile Corp. - February 24, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that it has received written notification from The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has evidenced compliance with Nasdaq Listing Rule 5550(b)(2) through the alternatives permitted under Listing Rule 5550(b). As previously disclosed
Biotechnologies, Soins de santé et hôpitaux
2026-02-24 8:00 AM EST | Envoy Medical, Inc.
Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space
White Bear Lake, Minnesota--(Newsfile Corp. - February 23, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced the issuance of three new patents with one in the United States and two in Hong Kong, further expanding its intellectual property and reinforcing its competitive position in the cochlear implant industry. "We believe the future of the cochlear implant industry
Biotechnologies, Soins de santé et hôpitaux
2026-02-23 8:00 AM EST | Envoy Medical, Inc.
Jones Healthcare Group Wins Best of Show and Best in Class Honours at PAC Global Awards for Qube(TM) Eco
London, Ontario--(Newsfile Corp. - February 20, 2026) - As healthcare systems face increasing pressure to reduce waste and carbon impact, packaging innovation must deliver measurable results without compromising patient safety or pharmacy workflow. At the same time, environmental claims across industries are under greater scrutiny, with regulators, retailers and consumers demanding proof over promise. At the 2026 PAC Global Awards ceremony, held February 18-19 in Toronto, Jones Healthca
Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-02-20 12:36 PM EST | Jones Healthcare Group
Apolo V Acquisition Corp. Amendment to Definitive Agreement with TelyRx, Inc. and Rescheduling of Special Meeting of Shareholders
Toronto, Ontario--(Newsfile Corp. - February 20, 2026) - Apolo V Acquisition Corp. (TSXV: AFV.P) ("Apolo V" or the "Company") announces it has amended its business combination agreement with TelyRx, Inc. ("TelyRx") dated January 19, 2026 (the "Business Combination Agreement") effected in connection with its previously announced proposed qualifying transaction (the "Qualifying Transaction") and postponed its special meeting of shareholders (the "Meeting
Soins de santé et hôpitaux, Santé
2026-02-20 12:10 PM EST | TelyRx
Correcting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress
Toronto, Ontario--(Newsfile Corp. - February 20, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of canc
Technologies, Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique
2026-02-20 7:00 AM EST | Theralase Technologies Inc.